RxDoctor Payments Data

Joseph Farrell, DO

Orthopaedic Surgery · Lewes, DENPI 1831418912

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.3%), education and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 61.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $2,504 and has fallen 92.2% since, to $195 in 2025.

$8,516in general payments, 2019–2025

Across 51 payments — averaging $166.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$5K
  • Arthrex$2K
  • Supreme Orthopedic Systems, LLC$257
  • UOC USA Inc$212
  • Linvatec Corporation$164
  • Zimmer Biomet$123
  • plus $262 from 5 others

What the payments were for

  • Travel & lodging$4,62354%
  • Food & beverage$1,91522%
  • Education$1,97823%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,516 in reported general payments places this provider in the 60th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$716,955
Medicare patients
1,269
Services billed
16,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib357$7,678
Oxycodone Hcl208$1,007
Meloxicam164$933
Diclofenac Sodium67$843
Gabapentin44$617
Amoxicillin546$609
Tizanidine Hcl39$521
Mupirocin48$326
Methylprednisolone44$280
Clindamycin Hcl94$179
Tramadol Hcl35$100
Prednisone19$66
Hydromorphone Hcl12$52
Cyclobenzaprine Hcl11$47

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Lewes

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →